Sonoporation as an enhancing method for boron neutron capture therapy for squamous cell carcinomas

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Yamatomo, Naofumi ^a   Iwagami, Takaki ^b   Kato, Itsuro ^b   Masunaga, Shin Ichiro ^c   Sakurai, Yoshinori ^c   Iwai, Soichi ^b   Nakazawa, Mitsuhiro ^b   Ono, Koji ^c   Yura, Yoshiaki ^b  

^a Osaka Saiseikai Senri Hospital   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Boron neutron capture therapy; Microbubble; Oral squamous cell carcinoma; Ultrasound

Indexed keywords

4 BORONOPHENYLALANINE; BORON DERIVATIVE; BORONOCAPTATE SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; FEMALE; HUMAN; HUMAN CELL; MICROBUBBLE; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NEUTRON; NEUTRON CAPTURE THERAPY; NEUTRON RADIATION; NONHUMAN; SONOPORATION; SURVIVAL RATE; TUMOR VOLUME; ULTRASOUND THERAPY;

ANIMALS; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MEMBRANE; FEMALE; HUMANS; ISOTOPES; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROBUBBLES; MOUTH NEOPLASMS; NEOPLASM TRANSPLANTATION; NEUTRONS; PHENYLALANINE; RADIOTHERAPY; ULTRASONICS;

EID: 84888614987     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-280     Document Type: Article

References (30)

1. Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, Gay EG, Langer CJ. National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 2009, 31:748-758. 10.1002/hed.21022, 19189340.
2. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2002, 345:1890-1900.
3. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005, 114:806-816. 10.1002/ijc.20740, 15609302.
4. Coderre JA, Morris GM. The radiation biology of boron neutron capture therapy. Radiat Res 1999, 151:1-18. 10.2307/3579742, 9973079.
5. Barth RF, Coderre JA, Vicente MG, Blue TE. Boron neutron capture therapy of cancer: Current status and future prospects. Clin Cancer Res 2005, 11:3987-4002. 10.1158/1078-0432.CCR-05-0035, 15930333.
6. Tachibana K, Uchida T, Ogawa K, Yamashita N, Tamura K. Induction of cell-membrane porosity by ultrasound. Lancet 1999, 353:1409.
7. Newman CM, Lawrie A, Brisken AF, Cumberland DC. Ultrasound gene therapy: on the road from concept to reality. Echocardiography 2001, 18:339-347. 10.1046/j.1540-8175.2001.00339.x, 11415507.
8. Fechheimer M, Boylan JF, Parker S, Sisken JE, Patel GL, Zimmer SG. Transfection of mammalian cells with plasmid DNA by scrape loading and sonication loading. Proc Natl Acad Sci U S A 1987, 84:8463-8467. 10.1073/pnas.84.23.8463, 299564, 2446324.
9. Escoffre JM, Zeghimi A, Novell A, Bouakaz A. In-vivo gene delivery by sonoporation: recent progress and prospects. Curr Gene Ther 2013, 13:2-14. 10.2174/156652313804806606, 23157546.
10. Tsutsui JM, Xie F, Porter RT. The use of microbubbles to target drug delivery. Cardiovasc Ultrasound 2004, 2:23. 10.1186/1476-7120-2-23, 538251, 15546496.
11. Hernot S, Klibanov AL. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 2008, 60:1153-1166. 10.1016/j.addr.2008.03.005, 2720159, 18486268.
12. Watanabe Y, Aoi A, Horie S, Tomita N, Mori S, Morikawa H, Matsumura Y, Vassaux G, Kodama T. Low-intensity ultrasound and microbubbles enhance the antitumor effect of cisplatin. Cancer Sci 2008, 99:2525-2531. 10.1111/j.1349-7006.2008.00989.x, 19018767.
13. Li HL, Zheng XZ, Wang HP, Li F, Wu Y, Du LF. Ultrasound-targeted microbubble destruction enhances AAV-mediated gene transfection in human RPE cells in vitro and rat retina in vivo. Gene Ther 2009, 16:1146-1153. 10.1038/gt.2009.84, 19571889.
14. Kowalczuk L, Boudinet M, el Sanharawi M, Touchard E, Naud MC, Saïed A, Jeanny JC, Behar-Cohen F, Laugier P. In vivo gene transfer into the ocular ciliary muscle mediated by ultrasound and microbubbles. Ultrasound Med Biol 2011, 37:1814-1827. 10.1016/j.ultrasmedbio.2011.07.010, 21963032.
15. Bokor D. Diagnostic efficacy of SonoVue. Am J Cardiol 2000, 86(4A):19G-24G.
16. Sidhu PS, Allan PL, Cattin F, Cosgrove DO, Davies AH, Do DD, Karakagil S, Langholz J, Legemate DA, Martegani A, Llull JB, Pezzoli C, Spinazzi A. Diagnostic efficacy of SonoVue, a second generation contrast agent, in the assessment of extracranial carotid or peripheral arteries using colour and spectral Doppler ultrasound: a multicentre study. Br J Radiol 2006, 79:44-51. 10.1259/bjr/23954854, 16421404.
17. Shintani M, Takahashi G, Hamada M, Okunaga S, Iwai S, Yura Y. Effect of ultrasound on herpes simplex virus infection in cell culture. Virology J 2011, 8:446.
18. Coderre JA, Button TM, Micca PL, Fisher CD, Nawrocky MM, Liu HB. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex. Int J Radiat Oncol Biol Phys 1994, 30:643-652. 10.1016/0360-3016(92)90951-D, 7928496.
19. Kamida A, Fujita Y, Kato I, Iwai S, Ono K, Suzuki M, Sakurai Y, Yura Y. Effect of neutron capture therapy on the cell cycle of human squamous cell carcinoma cells. Int J Radiat Biol 2008, 84:191-199. 10.1080/09553000801902125, 18300019.
20. Obayashi S, Kato I, Ono K, Masunaga S, Suzuki M, Nagata K, Sakurai Y, Yura Y. Delivery of 10boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy. Oral Oncol 2004, 40:474-482. 10.1016/j.oraloncology.2003.09.018, 15006618.
21. Mishima Y, Honda C, Ichihashi M, Obara H, Hiratsuka J, Fukuda H, Karashima H, Kobayashi T, Kanda K, Yoshino K. Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound. Lancet 1989, 2:388-389.
22. Ono K, Masunaga SI, Kinashi Y, Takagaki M, Akaboshi M, Kobayashi T, Akuta K. Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy. Int J Radiat Oncol Biol Phys 1996, 34:1081-1086. 10.1016/0360-3016(95)02180-9, 8600091.
23. Masunaga S, Ono K, Takahashi A, Sakurai Y, Ohnishi K, Kobayashi T, Kinashi Y, Takagaki M, Ohnishi T. Impact of the p53 status of the tumor cells on the effect of reactor neutron beam irradiation, with emphasis on the response of intratumor quiescent cells. Jpn J Cancer Res 2002, 93:1366-1377. 10.1111/j.1349-7006.2002.tb01246.x, 12495477.
24. Detta A, Cruickshank GS. L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors. Cancer Res 2009, 69:2126-2132.
25. Haase C, Bergmann R, Fuechtner F, Hoepping A, Pietzsch J. L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo. J Nucl Med 2007, 48:2063-2071. 10.2967/jnumed.107.043620, 18056335.
26. Teissié J, Escoffre JM, Paganin A, Chabot S, Bellard E, Wasungu L, Rols MP, Golzio M. Drug delivery by electropulsation: Recent developments in oncology. Int J Pharm 2012, 423:3-6. 10.1016/j.ijpharm.2011.09.038, 21996516.
27. Cemazar M, Skrk J, Mitrovic B, Sersa G. Changed delivery of boron to tumours using electroporation for boron neutron capture therapy with BSH. Br J Radiol 2000, 73:195-200.
28. Doi A, Kawabata S, Iida K, Yokoyama K, Kajimoto Y, Kuroiwa T, Shirakawa T, Kirihata M, Kasaoka S, Maruyama K, Kumada H, Sakurai Y, Masunaga S, Ono K, Miyatake S. Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy. J Neurooncol 2008, 87:287-294. 10.1007/s11060-008-9522-8, 18219552.
29. El-Zaria ME, Nakamura H. New strategy for synthesis of mercaptoundecahydrododecaborate derivatives via click chemistry: possible boron carriers and visualization in cells for neutron capture therapy. Inorg Chem 2009, 48:11896-11902. 10.1021/ic902033c, 19928788.
30. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257. 10.1038/35025220, 11001068.